SEER Cancer Statistics Review 1975-2016 National Cancer Institute · 2019-04-11 · Expected survival rates are derived from life tables by socio-economic status, geography and race

SEER Cancer Statistics Review 1975-2016 National Cancer Institute

Note: Incidence and death rates are per 100,000 and are age-adjusted to the 2000 US StdPopulation (19 age groups - Census P25-1130).

a SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle,Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia,California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey,Georgia excluding ATL/RG, Idaho, New York and Massachusetts).

b US Mortality Files, National Center for Health Statistics, Centers for Disease Control andPrevention.

c SEER 18 areas. Based on follow-up of patients into 2016. Expected survival rates arederived from life tables by socio-economic status, geography and race developed by theSEER program.

d Mesotheliomas of the Pleura are included in the separate group Mesothelioma for incidencebut are included in the Pleura grouping for mortality.

- Statistic could not be calculated due to less than 16 cases in the time interval.

Incidencea US Mortalityb Survivalc (%)(2012-2016) (2012-2016) (2009-2015)

Site Total Males Females Total Males Females Total Males Females

All Sites 442.0 481.0 417.1 161.0 193.1 137.7 67.1 66.3 68.0

Oral Cavity & Pharynx: 11.3 17.0 6.4 2.5 3.9 1.3 65.3 64.6 67.1Lip 0.6 1.0 0.3 0.0 0.0 0.0 89.7 90.0 89.0Tongue 3.5 5.2 1.9 0.6 1.0 0.4 66.4 66.8 65.3Salivary gland 1.3 1.7 1.0 0.3 0.4 0.2 71.4 64.2 81.4Floor of mouth 0.5 0.7 0.3 0.0 0.0 0.0 51.7 49.4 56.8Gum & other oral cavity 1.5 1.9 1.3 0.4 0.5 0.3 59.0 55.4 63.3Nasopharynx 0.6 0.9 0.4 0.2 0.3 0.1 61.3 59.5 65.6Tonsil 2.0 3.4 0.7 0.2 0.4 0.1 74.3 74.9 71.2Oropharynx 0.5 0.8 0.2 0.3 0.4 0.1 47.1 48.5 41.2Hypopharynx 0.6 1.0 0.2 0.1 0.2 0.0 34.6 34.3 36.2Other oral cavity & pharynx 0.3 0.4 0.1 0.4 0.7 0.2 46.6 49.2 36.9

Digestive System: 81.0 98.7 66.4 41.1 52.7 31.6 43.5 41.1 46.4Esophagus 4.3 7.3 1.8 4.0 7.1 1.5 19.9 19.4 21.5Stomach 7.4 10.0 5.3 3.1 4.2 2.3 31.5 28.7 35.7Small intestine 2.4 2.7 2.1 0.4 0.5 0.3 68.0 67.9 68.2Colon & Rectum: 38.6 44.2 33.9 14.2 16.9 11.9 64.4 64.0 64.9Colon 27.1 29.9 24.8 - - - 63.4 63.2 63.5Rectum 11.5 14.3 9.1 - - - 66.7 65.4 68.5

Anus, anal canal & anorectum 1.9 1.6 2.2 0.3 0.2 0.3 68.3 61.9 72.0Liver & intrahepatic 8.8 13.6 4.7 6.5 9.6 3.9 18.4 18.0 19.5bile duct

Gallbladder 1.2 0.9 1.5 0.6 0.4 0.7 18.5 19.3 18.2Other biliary 1.9 2.3 1.5 0.4 0.5 0.4 17.9 19.0 16.6Pancreas 12.9 14.6 11.5 11.0 12.6 9.6 9.3 9.4 9.2Retroperitoneum 0.4 0.4 0.4 0.1 0.1 0.1 54.8 53.1 56.3Peritoneum, omentum & 0.5 0.1 0.8 0.3 0.1 0.4 32.4 34.4 32.3mesentery

Other digestive system 0.7 0.8 0.6 0.3 0.4 0.3 7.9 6.8 9.0

Respiratory System: 58.7 69.4 50.6 43.1 53.8 34.9 22.3 20.7 24.3Nose, nasal cavity & 0.7 0.9 0.5 0.1 0.2 0.1 57.9 58.5 57.1middle ear

Larynx 3.0 5.2 1.1 1.0 1.8 0.4 60.3 60.9 57.8Lung & bronchus 54.9 63.0 48.9 41.9 51.6 34.4 19.4 16.1 23.0Pleurad 0.0 0.0 0.0 0.1 0.1 0.0 25.8 20.3 32.9Trachea & other 0.2 0.3 0.1 0.1 0.1 0.0 53.8 53.1 55.7respiratory organs

Bones & joints 1.0 1.1 0.8 0.4 0.5 0.3 66.2 64.0 69.1

Soft tissue (including heart) 3.5 4.2 2.9 1.3 1.5 1.2 64.9 64.2 65.8

Skin (excl. basal & squamous): 24.3 31.6 19.0 3.5 5.4 2.0 91.6 89.7 94.1Melanoma of the skin 22.2 28.8 17.5 2.5 3.7 1.5 92.2 90.4 94.6Other non-epithelial skin 2.0 2.8 1.5 1.0 1.7 0.5 84.3 82.2 87.3

Breast 68.4 1.2 127.5 11.4 0.3 20.6 89.8 83.6 89.9

Breast (in situ) 17.5 0.1 33.2 - - - 100.0 100.0 100.0

Table 1.4Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent)

By Primary Cancer Site, Sex and Time Period

All Races

https://seer.cancer.gov/expsurvival/







d Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.e Due to coding changes, Brain & Nervous System mortality are no longer shown separately.f Rate not shown for mortality. Category did not exist in mortality coding until 1999.- Statistic could not be calculated due to less than 16 cases in the time interval.



Female Genital System: 27.1 - 51.0 8.3 - 15.1 69.5 - 69.5Cervix uteri 3.8 - 7.3 1.2 - 2.3 65.8 - 65.8Corpus uteri 14.2 - 26.7 1.2 - 2.1 82.6 - 82.6Uterus, NOS 0.5 - 0.8 1.5 - 2.6 28.8 - 28.8Ovaryd 6.1 - 11.4 3.9 - 7.0 47.6 - 47.6Vagina 0.4 - 0.7 0.1 - 0.2 46.7 - 46.7Vulva 1.4 - 2.5 0.3 - 0.5 71.1 - 71.1Other female genital system 0.8 - 1.5 0.2 - 0.3 52.0 - 52.0

Male Genital System: 53.4 116.5 - 8.1 19.7 - 97.7 97.7 -Prostate 50.0 109.5 - 7.8 19.2 - 98.0 98.0 -Testis 2.9 5.9 - 0.1 0.3 - 95.2 95.2 -Penis 0.4 0.9 - 0.1 0.2 - 66.7 66.7 -Other male genital system 0.1 0.3 - 0.0 0.0 - 82.6 82.6 -

Urinary System: 37.1 58.7 20.2 8.4 13.4 4.7 75.5 76.1 74.0Urinary bladder 20.1 35.2 8.7 4.4 7.6 2.1 77.1 78.3 73.2Kidney & renal pelvis 16.1 22.1 10.9 3.8 5.5 2.3 74.8 74.2 75.9Ureter 0.5 0.8 0.4 0.1 0.2 0.1 46.5 47.7 44.7Other urinary system 0.4 0.6 0.2 0.1 0.2 0.1 48.3 53.0 39.5

Eye & Orbit 0.9 1.0 0.8 0.1 0.1 0.1 83.3 83.3 83.4

Brain & Nervous System:e 6.4 7.5 5.4 4.4 5.4 3.6 32.9 31.6 34.6Brain 6.0 7.1 5.0 - - - 29.7 28.9 30.8Cranial nerves & other 0.4 0.4 0.4 - - - 79.9 76.9 83.0nervous system

Endocrine System: 16.6 8.9 24.0 0.8 0.8 0.8 96.6 92.5 97.9Thyroid 15.8 8.0 23.3 0.5 0.5 0.5 98.2 95.7 98.9Other endocrine & thymus 0.8 0.9 0.7 0.3 0.3 0.3 65.4 65.3 65.4

Lymphoma: 22.3 26.9 18.6 5.9 7.6 4.6 74.0 72.6 75.5Hodgkin lymphoma 2.7 3.0 2.3 0.3 0.4 0.2 86.6 85.6 87.8Non-Hodgkin lymphoma 19.6 23.9 16.2 5.6 7.3 4.4 72.0 70.7 73.7

Myeloma 6.9 8.7 5.6 3.3 4.2 2.7 52.2 52.1 52.4

Leukemia: 14.1 18.1 10.9 6.5 8.8 4.9 62.7 63.6 61.5Lymphocytic: 7.1 9.4 5.2 1.8 2.5 1.2 80.6 80.9 80.1Acute lymphocytic 1.7 1.9 1.5 0.4 0.5 0.4 68.6 68.2 69.2Chronic lymphocytic 4.9 6.8 3.5 1.2 1.8 0.8 85.1 85.0 85.3Other lymphocytic 0.4 0.6 0.2 0.1 0.2 0.1 82.0 85.7 70.4

Myeloid & Monocytic: 6.5 8.1 5.3 3.3 4.4 2.6 41.8 41.6 42.0Acute myeloid 4.3 5.2 3.5 2.8 3.6 2.2 28.3 27.5 29.3Chronic myeloid 1.9 2.4 1.4 0.3 0.4 0.2 69.2 68.2 70.6Acute monocytic 0.2 0.2 0.2 0.0 0.0 0.0 22.9 19.7 26.7Other myeloid & monocytic 0.1 0.2 0.1 0.2 0.3 0.2 36.3 37.6 34.6

Other leukemia: 0.5 0.6 0.4 1.4 1.9 1.1 33.5 33.7 33.3Other acute leukemia 0.2 0.3 0.2 0.5 0.6 0.4 24.8 25.3 24.2Aleukemic, subleukemic & NOS 0.3 0.3 0.2 1.0 1.3 0.7 40.2 40.4 39.7

Kaposi Sarcomaf 0.5 1.0 0.1 - - - 74.4 73.9 78.7Mesotheliomaf 0.9 1.6 0.4 - - - 10.3 8.0 16.9

Ill-defined & unspecified 7.6 8.8 6.7 11.8 14.8 9.4 18.5 21.7 15.2

Table 1.4 - continuedAge-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent)


All Races












All Sites 451.7 486.0 430.9 161.5 193.0 138.3 67.5 66.5 68.6

Oral Cavity & Pharynx: 11.9 17.9 6.6 2.5 3.8 1.3 66.7 66.4 67.7Lip 0.7 1.2 0.4 0.0 0.0 0.0 89.6 89.9 88.7Tongue 3.8 5.8 2.0 0.7 1.0 0.4 68.1 68.6 66.5Salivary gland 1.3 1.8 1.0 0.3 0.4 0.2 69.0 61.5 80.1Floor of mouth 0.5 0.7 0.3 0.0 0.0 0.0 53.1 50.8 57.7Gum & other oral cavity 1.6 1.9 1.3 0.4 0.5 0.3 58.9 55.5 63.0Nasopharynx 0.4 0.6 0.2 0.1 0.2 0.1 58.3 57.0 61.5Tonsil 2.2 3.8 0.7 0.3 0.4 0.1 75.6 76.0 73.0Oropharynx 0.5 0.8 0.2 0.3 0.4 0.1 50.6 52.0 44.7Hypopharynx 0.6 1.0 0.2 0.1 0.2 0.0 37.7 37.3 39.2Other oral cavity & pharynx 0.3 0.5 0.1 0.4 0.7 0.2 49.8 52.9 37.9






Larynx 3.0 5.2 1.2 1.0 1.7 0.4 61.5 62.1 59.2Lung & bronchus 56.7 63.5 51.8 42.7 51.7 35.6 19.5 16.2 23.0Pleurad 0.0 0.0 0.0 0.1 0.1 0.0 23.4 23.8 22.0Trachea & other 0.2 0.3 0.1 0.1 0.1 0.0 53.7 52.2 57.9respiratory organs

Bones & joints 1.0 1.2 0.9 0.5 0.6 0.4 66.0 63.7 69.2



Breast 69.2 1.2 130.5 11.1 0.3 20.1 90.8 85.9 90.8

Breast (in situ) 17.2 0.1 33.1 - - - 100.0 99.9 100.0



Whites














Eye & Orbit 1.0 1.2 0.9 0.1 0.1 0.1 82.5 82.2 82.8




Myeloma 6.3 8.1 4.9 3.1 4.0 2.4 51.3 51.3 51.3


Myeloid & Monocytic: 6.7 8.4 5.4 3.5 4.5 2.7 40.9 40.6 41.4Acute myeloid 4.4 5.4 3.6 2.9 3.7 2.2 27.9 27.0 29.0Chronic myeloid 1.9 2.5 1.5 0.3 0.4 0.2 68.1 67.1 69.5Acute monocytic 0.2 0.2 0.2 0.0 0.0 0.0 23.5 20.2 27.5Other myeloid & monocytic 0.2 0.2 0.1 0.2 0.4 0.2 33.6 33.9 33.0






Whites












All Sites 442.9 520.8 391.3 185.6 233.5 156.0 61.8 63.6 59.7

Oral Cavity & Pharynx: 8.6 13.4 5.0 2.7 4.7 1.3 48.4 46.7 52.0Lip 0.1 0.1 - - - - 69.9 66.6 -Tongue 2.0 3.2 1.1 0.5 0.8 0.3 44.3 45.3 42.0Salivary gland 1.1 1.1 1.1 0.2 0.3 0.1 76.4 71.3 81.0Floor of mouth 0.4 0.7 0.2 0.0 0.0 - 38.9 39.0 38.2Gum & other oral cavity 1.3 1.6 1.0 0.3 0.5 0.2 52.9 48.9 57.1Nasopharynx 0.7 1.0 0.4 0.2 0.4 0.1 52.5 53.7 49.9Tonsil 1.5 2.8 0.6 0.2 0.4 0.1 57.9 59.0 53.2Oropharynx 0.5 1.0 0.2 0.4 0.6 0.2 28.9 30.0 25.3Hypopharynx 0.8 1.5 0.3 0.2 0.3 0.0 19.8 20.2 17.3Other oral cavity & pharynx 0.2 0.4 0.1 0.6 1.2 0.2 30.4 29.4 32.6






Larynx 4.0 7.6 1.5 1.6 3.1 0.5 51.1 51.7 48.7Lung & bronchus 56.2 73.5 44.6 44.3 62.1 32.4 17.1 13.9 21.0Pleurad - - - 0.0 0.1 0.0 - - -Trachea & other 0.2 0.2 0.1 0.1 0.1 0.1 46.7 47.4 44.3respiratory organs

Bones & joints 0.8 0.8 0.7 0.4 0.6 0.4 65.2 64.7 65.8



Breast 70.9 1.8 124.0 16.4 0.5 28.1 81.4 72.5 81.5

Breast (in situ) 18.8 0.2 33.3 - - - 100.0 82.0 100.0



Blacks














Eye & Orbit 0.3 0.3 0.2 0.0 0.0 0.0 91.0 88.7 91.0




Myeloma 13.7 16.3 11.9 6.2 7.4 5.4 53.9 53.4 54.4


Myeloid & Monocytic: 5.7 6.9 5.0 2.7 3.4 2.2 43.9 43.6 44.1Acute myeloid 3.7 4.4 3.3 2.2 2.7 1.9 27.9 26.7 29.0Chronic myeloid 1.8 2.2 1.5 0.3 0.4 0.2 71.0 69.7 72.4Acute monocytic 0.1 0.2 0.1 0.0 0.0 - 25.5 26.3 24.4Other myeloid & monocytic 0.1 0.2 0.1 0.2 0.2 0.1 42.0 44.8 37.2






Blacks



0

50

100

150

200

250

300

350

400

450

500

550

600

650

700

SEER Incidence US Mortality

Black White

010203040506070

Male

0

50

100

150

200

250

300

350

400

450

500

550

600

650

700

SEER Incidence US Mortality

010203040506070

Female

Figure 1.9

SEER Incidence and US Death Rates, 2012-20165-Year Relative Survival, 2009-2015

All Cancer Combined, by Race and Sex

a b

c

Incidence rates are from the SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry,Rural Georgia,California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts) and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).Death rates are from the US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).Survival rates are from the SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

Males Females

Survival Survival

Rate per 100,000 Rate per 100,000

Percent (%) Percent (%)

a

b

c

SEE

R C

ancer Statistics Review

1975-2016N

ational Cancer Institute

99

98

95

92

91

87

84

78

78

75

73

67

67

66

64

63

61

51

48

32

30

21

19

18

10

9 9

17

15

17

13

32

39

39

54

51

57

57

63

48

55

67

75

65

64

62

84

81

67

92

96

97

Figure 1.11

5-Year Relative Survival (%)SEER Program, 2009-2015

Both Sexes, by Race and Cancer Site

White Patients Cancer Site Black Patients

Thyroid

Prostate

Testis

Melanoma of the Skin

Breast (Female)

Hodgkin Lymphoma

Corpus & Uterus, NOS

Kaposi Sarcoma

Urinary Bladder

Kidney & Renal Pelvis

Non-Hodgkin Lymphoma

Cervix Uteri

Oral Cavity & Pharynx

Rectum

Colon

Leukemia

Larynx

Myeloma

Ovary

Brain & ONS

Stomach

Esophagus

Lung & Bronchus

Liver & IBD

Mesothelioma

Pancreas

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.a

a


SEE

R C


1975-2016N


a Based on End Results data from a series of hospital registries and one population-based registry.b SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

Based on follow-up of patients into 2016. Expected survival rates are derived from the U.S. Annual Life Tables.c SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey,

Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey andGeorgia excluding ATL/RG). Expected survival rates are derived from life tables by socio-economic status, geography and racedeveloped by the SEER program.Based on follow-up of patients into 2016.

d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts. It is computed here using three year calendar blocks (2010-2012: 0-1 year survival),(2009-2011: 1-2 year survival), (2008-2010: 2-3 year survival), (2007-2009: 3-4 year survival), (2006-2008: 4-5 years survival).

e The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).f The standard error is between 5 and 10 percentage points.g The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.

All Races Whites Blacks Total Males Females Total Males Females Total Males Females

5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 39 - - 27 - -1970-1973a - - - 43 - - 31 - -1975-1977b 48.9 41.7 55.9 49.8 42.7 56.5 39.1 32.7 46.21978-1980b 49.0 43.1 55.0 50.0 44.3 55.6 39.0 33.3 45.61981-1983b 50.2 45.2 55.1 51.3 46.6 56.0 38.8 34.2 44.41984-1986b 52.4 47.2 57.6 53.6 48.6 58.6 40.2 35.5 45.51987-1989b 55.3 51.2 59.6 56.7 52.8 60.6 43.0 38.9 47.71990-1992b 59.9 59.1 60.9 61.4 60.8 62.1 47.9 47.7 48.21993-1995b 61.3 60.9 61.8 62.4 62.1 62.8 52.9 54.6 50.71996-1998b 63.3 63.0 63.7 64.4 64.1 64.7 55.4 58.1 52.21999-2001b 66.0 66.3 65.7 67.2 67.6 66.8 58.1 61.3 54.42002-2004b 67.1 67.7 66.5 68.4 69.0 67.7 59.7 63.4 55.52005-2008b 68.7 69.4 68.0 69.8 70.4 69.2 62.0 65.5 58.12009-2015b 69.3e 68.7e 70.0e 70.3e 69.6e 71.0e 63.6e 65.7e 61.4e

5-Year Period Survival (Percent)cd

2015 67.1 65.7 68.4 67.4 65.7 69.1 61.8 63.0 60.3

5-Year Relative Survival (Percent), 2009-2015c

Age at Diagnosis:Ages <45 82.9 78.8 85.5 84.3 80.3 86.8 73.3 68.1 76.2Ages 45-54 74.7 69.2 79.0 75.6 69.7 80.2 67.3 66.3 68.1Ages 55-64 70.0 68.7 71.6 70.8 69.1 72.8 63.4 65.0 61.1Ages 65-74 67.2 68.9 64.9 67.5 68.9 65.7 61.9 66.3 56.0Ages 75+ 50.7 52.9 48.6 51.3 52.9 49.7 43.2 47.8 39.6Ages <65 73.9 70.4 77.3 74.8 71.0 78.4 66.3 65.8 66.9Ages 65+ 59.7 62.3 56.7 60.0 62.2 57.6 54.8 60.5 48.6

Table 2.8All Cancer Sites (Invasive)

5-Year Relative and Period Survival (Percent) by Race, Sex, Diagnosis Year and Age


SEE

R C


1975-2016N






e Stage at diagnosis is classified using SEER Summary Stage 2000. Stage distribution percentages may not sum to 100 due to rounding.f The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).g The standard error is between 5 and 10 percentage points.h The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.


5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 18 16 21 19 17 211970-1973a - - - 20 18 22 19 19 191975-1977b 22.5 20.7 24.8 21.9 20.2 24.1 25.4 19.6 34.7g

1978-1980b 23.6 22.4 25.1 23.0 22.0 24.4 28.2 28.7 27.51981-1983b 24.1 23.0 25.5 23.4 22.4 24.6 30.8 31.7 29.2g

1984-1986b 26.9 25.6 28.5 26.2 24.8 27.8 30.9 32.8 28.51987-1989b 29.0 27.4 31.1 28.3 26.3 30.8 31.9 34.0 29.31990-1992b 30.2 30.5 29.7 29.2 29.4 28.9 39.3 40.2 38.11993-1995b 32.2 33.0 31.3 30.8 31.4 30.2 41.9 46.1 37.31996-1998b 31.3 30.7 32.1 30.6 30.2 31.0 35.9 33.6 38.31999-2001b 33.9 30.9 37.8 33.1 30.4 36.6 38.6 33.4 45.62002-2004b 35.1 34.2 36.1 34.2 33.9 34.5 39.4 33.3 45.82005-2008b 35.5 34.3 37.0 33.9 33.0 35.1 43.6 39.7 47.32009-2015b 34.0f 32.6f 35.7f 32.6f 31.1f 34.4f 39.8f 39.3f 40.2


2015 32.5 31.1 34.5 31.1 29.5 33.2 40.2 39.7 40.6

Stage Distribution (%) 2009-2015ce

All StagesNumber of cases 34,898 19,445 15,453 29,776 16,710 13,066 2,532 1,328 1,204Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 77 78 77 78 78 77 77 78 75Regional 15 15 15 15 15 15 15 13 16Distant 2 3 2 2 2 2 3 3 4Unstaged/Unknown 5 4 6 5 4 5 5 5 5


Age at Diagnosis:Ages <45 69.2 67.1 71.9 69.8 67.7 72.6 65.6 63.5 67.8Ages 45-54 32.5 29.5 36.8 32.3 29.1 36.9 28.9 26.3 32.4Ages 55-64 15.8 14.2 18.1 15.2 13.8 17.2 17.5 12.8 23.3Ages 65-74 9.0 7.7 10.7 8.9 7.2 11.0 8.6 10.9 7.2Ages 75+ 4.3 4.2 4.4 3.9 4.1 3.8 8.5 - 9.0Ages <65 44.9 42.2 48.7 44.0 41.2 47.9 47.0 43.4 51.1Ages 65+ 6.9 6.2 7.6 6.6 5.9 7.4 8.6 9.5 7.8

Stagee:All Stages 32.9 31.6 34.6 31.7 30.4 33.4 38.7 37.1 40.4Localized 35.7 34.3 37.6 34.5 33.0 36.5 40.7 39.7 41.7Regional 20.2 19.6 21.0 19.2 18.7 19.8 26.2 20.5 31.3Distant 32.4 29.3 36.8 30.9 27.9 35.3 42.2g 39.8g 45.5g

Unstaged/Unknown 28.2 27.4 28.9 25.5 24.6 26.3 42.3 39.0g 45.2g

Table 3.8Cancer of the Brain and Other Nervous System (Invasive)

5-Year Relative and Period Survival (Percent) by Race, Sex, Diagnosis Year, Stage and Age


SEE

R C


1975-2016N






e Stage at diagnosis is classified using SEER Summary Stage 2000. Stage distribution percentages may not sum to 100 due to rounding.f The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).g The standard error is between 5 and 10 percentage points.h The standard error is greater than 10 percentage points.j In situ cases are not included in the All Stages group.- Statistic could not be calculated due to fewer than 25 cases during the time period.

All Races, Females White Females Black Females All <50 50+ All <50 50+ All <50 50+

5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 63 - - 46 - -1970-1973a - - - 68 - - 51 - -1975-1977b 74.8 76.5 74.3 75.6 77.8 74.9 62.2 62.4 62.01978-1980b 74.4 75.5 74.1 75.1 76.1 74.9 63.4 67.0 61.51981-1983b 76.1 77.4 75.7 77.1 78.5 76.7 63.4 65.1 62.61984-1986b 79.0 77.8 79.3 80.0 79.5 80.2 65.1 64.0 65.91987-1989b 84.0 81.4 85.0 85.1 82.7 85.9 71.1 69.6 71.91990-1992b 85.2 83.4 85.9 86.5 85.1 87.0 71.5 70.1 72.41993-1995b 86.4 84.3 87.1 87.6 86.2 88.1 72.8 70.5 74.21996-1998b 88.2 86.6 88.8 89.4 88.3 89.7 76.2 74.0 77.61999-2001b 89.7 88.1 90.3 90.8 89.9 91.1 79.0 77.0 80.22002-2004b 90.0 89.3 90.2 91.4 91.1 91.5 77.9 77.6 78.22005-2008b 90.8 91.2 90.7 92.1 92.6 92.0 80.3 81.6 79.62009-2015b 91.3f 91.1f 91.4f 92.4f 92.4f 92.4f 83.4f 83.3f 83.5f

5-Year Period Survival (Percent)cd2015 90.0 89.6 90.2 91.0 90.7 91.1 81.8 81.0 82.2

Stage Distribution (%) 2009-2015ceAll StagesNumber of cases 350,242 79,150 271,092 275,036 57,813 217,223 39,698 10,672 29,026Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 62 55 65 64 55 66 54 47 57Regional 30 39 28 29 39 27 35 43 33Distant 6 5 6 6 5 6 9 8 9Unstaged/Unknown 2 1 2 1 1 2 2 2 2

5-Year Relative Survival (Percent), 2009-2015cAge at Diagnosis:Ages <45 88.1 - - 89.3 - - 79.0 - -Ages 45-54 90.8 - - 91.9 - - 82.3 - -Ages 55-64 90.5 - - 91.4 - - 82.8 - -Ages 65-74 91.9 - - 92.5 - - 84.8 - -Ages 75+ 86.3 - - 87.3 - - 74.8 - -Ages <65 90.1 - - 91.2 - - 81.7 - -Ages 65+ 89.6 - - 90.3 - - 80.9 - -

Stagee:All Stages 89.9 89.6 90.0 90.8 90.8 90.9 81.5 80.8 81.7Localized 98.8 97.0 99.3 99.2 97.4 99.7 95.5 94.0 96.0Regional 85.5 86.9 84.9 86.6 88.3 86.0 77.1 77.9 76.7Distant 27.4 37.1 24.8 28.6 40.6 25.8 19.7 25.9 17.4Unstaged/Unknown 54.5 75.1 49.7 52.1 76.2 47.6 49.3 65.5 43.1In Situ j 100.0 100.0 100.0 100.0 100.0 100.0 100.0 99.8 100.0

Table 4.13Cancer of the Female Breast (Invasive)

5-Year Relative and Period Survival (Percent) by Race, Diagnosis Year, Stage and Age


SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 58 - - 47 - -1970-1973a - - - 64 - - 61 - -1975-1977b 69.1 82.5 57.9 69.7 83.9 58.1 64.6 75.6 55.11978-1980b 67.4 78.4 57.8 68.1 79.8 58.2 61.1 70.7 52.01981-1983b 66.9 79.6 54.6 67.8 80.8 54.9 59.2 73.6 46.21984-1986b 67.2 77.8 55.3 68.8 79.4 56.4 57.8 68.0 48.11987-1989b 70.1 79.6 58.0 72.5 82.6 58.5 56.9 62.7 51.81990-1992b 69.6 79.1 56.8 70.9 81.3 56.4 58.1 63.8 51.01993-1995b 72.7 81.8 59.9 74.2 83.5 60.1 62.8 70.7 53.31996-1998b 72.6 80.9 60.5 73.7 82.7 59.2 65.1 67.8 61.91999-2001b 72.4 84.0 56.3 73.3 85.7 55.0 66.2 74.1 56.92002-2004b 69.3 79.3 55.9 70.3 81.3 54.6 64.2 72.1 54.62005-2008b 70.3 80.2 57.2 71.8 82.8 56.8 60.4 64.9 55.32009-2015b 69.3 79.8f 56.5 71.1 82.0 57.5 57.7f 69.5 45.9f


2015 65.5 76.4 53.7 67.1 77.8 54.8 55.5 66.5 45.2




Age at Diagnosis:Ages <45 78.7 - - 80.1 - - 67.9 - -Ages 45-54 65.6 - - 67.3 - - 55.5 - -Ages 55-64 56.6 - - 57.1 - - 47.2 - -Ages 65-74 52.8 - - 52.3 - - 48.9 - -Ages 75+ 33.8 - - 34.4 - - 27.5 - -Ages <65 70.0 - - 71.5 - - 59.1 - -Ages 65+ 45.5 - - 45.5 - - 40.4 - -

Stagee:All Stages 65.8 76.4 53.9 67.2 77.9 54.6 55.4 65.9 45.5Localized 91.8 93.9 87.3 92.3 94.6 87.3 87.1 89.8 82.5Regional 56.3 61.6 52.0 57.2 62.8 52.4 49.4 56.0 44.1Distant 16.9 20.4 15.2 18.5 23.6 15.9 10.6 9.5 11.2Unstaged/Unknown 49.0 70.7 32.2 48.5 71.2 30.1 42.8 58.5g 31.8g

Table 5.8Cancer of the Cervix Uteri (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - - - - - - -1970-1973a - - - - - - - - -1975-1977b 49.8 49.0 50.7 50.1 49.4 50.8 44.7 43.4 45.91978-1980b 51.2 50.2 52.2 51.6 50.6 52.5 45.4 43.4 46.91981-1983b 54.0 53.8 54.2 54.4 54.4 54.3 46.5 42.9 49.51984-1986b 57.7 57.7 57.6 58.4 58.5 58.3 48.4 47.5 49.11987-1989b 59.6 59.8 59.3 60.1 60.6 59.5 52.3 49.9 54.51990-1992b 61.2 61.0 61.3 61.9 61.7 62.1 52.9 54.4 51.51993-1995b 59.9 59.8 60.0 60.5 60.3 60.7 51.7 51.3 52.01996-1998b 62.4 62.4 62.5 63.0 62.9 63.2 54.0 55.2 53.01999-2001b 65.2 66.1 64.1 66.6 67.4 65.7 54.4 56.0 53.02002-2004b 65.8 65.8 65.9 66.8 67.1 66.4 56.6 55.6 57.52005-2008b 66.7 66.7 66.6 67.6 68.0 67.2 58.8 56.4 60.92009-2015b 66.2f 66.1f 66.2f 66.9f 67.0f 66.8f 59.5f 58.4f 60.6f


2015 64.4 63.7 65.1 64.9 64.3 65.5 58.1 55.7 60.3





Stagee:All Stages 64.4 64.0 64.9 64.9 64.5 65.3 58.4 56.2 60.4Localized 89.9 89.3 90.6 90.1 89.3 91.1 86.9 85.7 87.9Regional 71.3 71.0 71.6 71.9 71.8 72.0 66.1 64.0 68.2Distant 14.2 13.1 15.3 14.6 13.7 15.6 11.0 9.5 12.4Unstaged/Unknown 35.4 38.7 32.4 31.8 35.4 28.5 38.8 39.1 38.5

Table 6.12Cancer of the Colon and Rectum (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 43 42 44 34 32 351970-1973a - - - 49 47 50 37 36 381975-1977b 50.6 50.1 51.1 50.9 50.5 51.3 44.8 44.1 45.31978-1980b 52.3 51.3 53.2 52.5 51.3 53.4 48.9 47.5 49.81981-1983b 55.2 55.6 54.8 55.4 56.2 54.8 48.5 44.7 51.51984-1986b 58.3 58.8 57.8 59.0 59.6 58.5 49.2 49.0 49.31987-1989b 60.2 60.8 59.7 60.7 61.4 59.9 52.4 50.7 53.81990-1992b 62.0 62.3 61.7 62.8 63.1 62.5 53.4 54.6 52.41993-1995b 59.8 60.2 59.5 60.5 60.7 60.3 51.1 51.2 50.91996-1998b 62.1 62.4 61.9 62.9 62.9 62.8 53.7 55.9 51.91999-2001b 64.9 66.2 63.7 66.6 67.9 65.5 52.7 54.2 51.62002-2004b 64.8 64.7 64.9 65.7 65.8 65.7 55.6 55.1 56.02005-2008b 66.1 66.5 65.7 67.3 68.0 66.7 56.9 55.5 58.02009-2015b 64.9f 65.1f 64.7f 66.1f 66.4f 65.9f 56.2f 56.4f 56.0f


2015 63.1 62.7 63.5 64.0 63.5 64.4 56.0 55.1 56.8






Table 6.13Cancer of the Colon (Invasive)



SEE

R C


1975-2016N










2015 67.2 65.6 69.3 66.9 65.8 68.3 63.6 57.3 71.0






Table 6.14Cancer of the Rectum (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 73 - - 31 - -1970-1973a - - - 81 - - 44 - -1975-1977b 86.9 92.7 86.2 88.0 93.3 87.4 60.2 84.4g 55.61978-1980b 82.5 91.7 81.3 83.7 93.0 82.6 54.9 82.3g 49.51981-1983b 80.7 91.2 79.4 82.2 92.3 81.1 50.7 82.8g 45.61984-1986b 82.5 93.6 81.1 84.0 93.9 82.8 56.2 83.5g 52.71987-1989b 82.3 89.8 81.2 83.9 90.9 83.0 56.7 82.8g 52.91990-1992b 83.7 90.1 82.7 85.8 92.3 84.9 54.0 72.9g 50.21993-1995b 83.2 90.0 82.0 84.9 91.5 83.8 58.6 81.7 54.01996-1998b 83.5 90.1 82.4 85.2 91.3 84.2 61.7 82.2 57.31999-2001b 84.2 88.7 83.3 85.9 89.9 85.2 61.4 70.9 58.92002-2004b 83.0 90.1 81.6 85.3 92.5 84.1 60.4 78.0 55.92005-2008b 83.6 88.3 82.8 85.7 90.1 85.0 65.1 73.7 63.42009-2015b 82.9f 89.0f 82.0f 85.6f 90.1f 85.0f 64.2f 81.9 61.5f


2015 81.0 87.8 79.9 83.3 89.0 82.5 62.1 77.4 59.8





Stagee:All Stages 81.2 88.2 80.0 83.5 89.2 82.7 62.2 79.4 59.6Localized 95.0 96.3 94.8 95.9 96.6 95.8 85.8 92.3 84.6Regional 69.0 81.2 67.3 71.6 82.2 70.4 49.8 72.5 47.2Distant 16.8 31.2 14.8 18.1 32.5 16.1 9.7 25.4 8.1Unstaged/Unknown 52.9 89.0 45.6 52.0 89.3 45.5 43.6 81.5g 37.7

Table 7.8Cancer of the Corpus and Uterus, NOS (Invasive)



SEE

R C


1975-2016N










2015 20.6 19.9 23.6 21.5 20.9 24.2 13.5 11.9 16.9


All StagesNumber of cases 21,583 17,092 4,491 18,182 14,681 3,501 2,160 1,459 701Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 18 18 21 19 18 21 16 15 19Regional 32 32 32 32 32 31 32 31 34Distant 40 41 33 40 41 33 41 44 35Unstaged/Unknown 10 9 14 10 8 14 11 10 13


Age at Diagnosis:Ages <45 20.0 18.4 26.3 19.5 19.0 22.0g 17.1g 7.2 -Ages 45-54 21.2 20.3 26.1 22.6 21.7 28.5 13.1 12.2 15.0Ages 55-64 21.3 20.4 26.0 23.0 22.2 28.0 11.9 8.9 19.1Ages 65-74 23.0 22.1 26.9 23.8 22.9 28.1 14.8 13.0 17.8Ages 75+ 13.4 13.7 12.8 13.4 13.9 12.5 11.7 10.5 12.2Ages <65 21.2 20.3 26.1 22.7 21.9 27.7 12.5 9.9 18.9Ages 65+ 18.7 18.7 18.8 19.1 19.2 18.8 13.6 12.3 15.5

Stagee:All Stages 19.9 19.4 21.5 20.7 20.4 21.9 13.0 10.8 17.4Localized 46.7 49.2 38.4 48.4 51.1 38.7 29.2 27.0 32.5g

Regional 25.1 24.3 28.4 26.0 25.3 29.4 18.0 16.1 21.5Distant 4.8 4.2 8.1 4.9 4.4 7.7 3.5 1.9 7.2Unstaged/Unknown 12.7 12.6 12.9 12.9 13.0 12.7 9.4 7.7 11.7

Table 8.8Cancer of the Esophagus (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 40 34 48 - - -1970-1973a - - - 67 66 69 - - -1975-1977b 71.8 69.9 74.3 72.1 70.1 74.6 70.1 68.5g 73.3g

1978-1980b 71.7 70.3 73.5 71.8 69.8 74.3 70.6 74.7g 63.1g

1981-1983b 74.3 72.9 76.0 74.6 73.7 75.7 71.8 69.6g 75.9g

1984-1986b 78.4 76.6 80.7 78.8 76.9 81.2 74.9 76.0g 72.1g

1987-1989b 79.2 76.6 82.5 79.7 76.8 83.3 72.3 70.9g 74.0g

1990-1992b 81.8 79.3 84.7 82.9 81.1 85.0 74.3 65.2 84.31993-1995b 81.7 79.3 84.6 82.2 80.1 84.7 78.3 74.0 83.01996-1998b 85.1 84.4 85.9 85.7 84.4 87.3 81.2 84.4 77.71999-2001b 85.1 82.8 87.9 85.7 84.0 87.8 81.6 75.4 89.82002-2004b 86.2 85.2 87.2 87.7 86.9 88.5 79.2 74.4 82.82005-2008b 89.0 87.9 90.2 89.5 88.8 90.2 86.6 83.3 90.32009-2015b 88.5f 87.5f 89.9f 89.3f 88.5f 90.4f 85.1f 81.6f 89.2f


2015 86.7 85.4 88.3 87.2 85.8 88.8 83.8 81.9 86.2




Age at Diagnosis:Ages <45 94.4 93.6 95.3 95.2 94.7 95.7 89.5 85.8 93.7Ages 45-54 85.8 83.6 89.6 87.2 85.8 89.6 79.6 74.6 86.8Ages 55-64 79.3 78.1 80.8 80.0 78.8 81.6 71.7 69.0 73.8g

Ages 65-74 67.4 66.2 68.8 66.7 64.4 69.7 68.9g 77.3h 59.8h

Ages 75+ 46.2 46.8 45.2 47.0 46.4 46.9 39.5g - -Ages <65 91.2 89.8 92.9 92.0 90.9 93.3 85.7 81.9 90.3Ages 65+ 58.0 58.4 57.4 58.0 56.9 58.7 61.2g 70.0g 52.8g

Stagee:All Stages 86.6 85.6 87.8 86.8 85.9 87.9 84.1 81.2 87.5Localized 91.6 91.5 91.6 91.5 91.3 91.6 91.6 91.9 91.0Regional 93.5 92.3 94.6 93.5 92.3 94.7 93.0 91.0 94.1Distant 78.4 78.5 78.2 78.7 79.3 77.7 76.2 72.7 81.4Unstaged/Unknown 83.0 81.6 84.4 81.8 78.6 85.2 77.2g 85.6g 68.2g

Table 9.8Hodgkin Lymphoma



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - - - - - - -1970-1973a - - - - - - - - -1975-1977b 80.7f 80.1f - 79.9f 79.0f - - - -1978-1980b 78.3f 79.4f 73.1g 78.0f 78.4f 72.5g - - -1981-1983b 35.7 33.4 64.3g 34.0 31.6 64.2g - - -1984-1986b 13.0 11.7 70.5g 12.8 11.4 70.2g 16.8 15.7 -1987-1989b 9.9 9.3 68.5g 9.4 8.8 72.3g 12.4 11.3 -1990-1992b 9.3 8.5 53.9f 8.9 8.2 55.4f 11.8 10.8 -1993-1995b 21.8 21.1 53.8f 22.1 21.3 62.1g 17.5 16.7 -1996-1998b 52.4 51.5 71.4g 57.0 55.8 85.9f 40.2 39.7 -1999-2001b 58.2 57.8 61.0f 64.8 63.1 79.2f 44.1 45.6 -2002-2004b 64.7 63.8 71.1g 75.2 74.1 76.9g 42.0 42.2 -2005-2008b 74.0 74.0 70.4f 80.7 80.7 75.2f 60.9 61.0 -2009-2015b 76.4e 76.4 75.3f 82.5 82.3 79.1f 64.5 65.6 37.3g


2015 75.4 74.8 79.3 77.7 76.5 81.5 66.2 67.8 35.6


Age at Diagnosis:Ages <45 68.6 69.3 44.8g 71.8 71.9 - 62.6 63.7 38.6g

Ages 45-54 73.3 73.6 - 74.6 74.3 - 66.0 68.0 -Ages 55-64 79.7 79.6 - 80.9 79.7 - 74.7f 79.6f -Ages 65-74 85.9 86.4 82.2f 85.7 85.0 86.8f - - -Ages 75+ 84.5 81.9f 82.9f 84.1 83.0f 80.1f - - -Ages <65 71.5 71.9 59.6f 74.4 74.1 84.1f 64.1 65.6 33.9g

Ages 65+ 86.0 84.5 84.0 86.0 84.3 83.1f 69.8g - -

Table 10.6Kaposi Sarcoma



SEE

R C


1975-2016N









1978-1980b 52.9 52.7 53.3 52.6 52.8 52.1 56.9 51.9 62.8g

1981-1983b 50.0 51.1 48.2 49.9 51.2 47.6 50.6 50.2 51.21984-1986b 54.5 55.0 53.7 54.7 55.4 53.5 52.6 49.2 57.51987-1989b 56.7 57.1 56.1 57.3 58.0 56.1 54.8 53.0 57.01990-1992b 60.2 60.6 59.6 60.7 61.3 59.7 57.0 55.2 59.11993-1995b 61.5 61.7 61.1 62.0 62.9 60.7 57.6 54.2 62.11996-1998b 62.5 62.9 61.9 62.1 62.6 61.2 66.9 68.1 64.51999-2001b 64.9 63.4 67.2 64.9 63.6 66.9 64.1 59.4 69.42002-2004b 69.2 69.5 68.9 69.3 69.8 68.7 65.5 64.7 66.72005-2008b 74.5 73.5 76.0 74.5 73.5 76.0 74.7 73.5 76.52009-2015b 75.5f 74.8f 76.6f 75.3f 74.7f 76.4f 77.1f 77.1f 77.2f


2015 75.3 74.4 76.8 75.2 74.2 76.8 76.8 75.8 78.3






Table 11.8Cancer of the Kidney and Renal Pelvis (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 53 54 46 - - -1970-1973a - - - 62 63 56 - - -1975-1977b 66.0 66.6 62.6 66.7 67.4 62.3 58.2 57.1 63.3g

1978-1980b 65.3 65.5 64.6 66.2 66.4 65.4 56.9 57.2 55.8g

1981-1983b 68.1 68.4 66.9 69.5 69.8 68.5 56.5 57.7 50.7g

1984-1986b 65.3 65.9 62.2 67.0 67.6 64.0 53.3 53.7 51.1g

1987-1989b 65.5 66.6 61.0 67.0 68.5 60.7 56.1 54.3 61.3g

1990-1992b 65.8 66.7 62.3 67.7 68.5 64.4 53.7 54.3 51.3g

1993-1995b 63.6 65.2 56.6 65.1 67.0 57.6 53.1 54.4 47.4g

1996-1998b 65.0 66.8 58.8 66.9 68.5 61.2 53.7 56.6 45.0g

1999-2001b 63.3 64.2 59.6 65.2 66.3 60.8 49.8 49.1 52.4g

2002-2004b 61.8 62.1 60.7 64.3 64.2 64.8 50.8 53.6 41.4g

2005-2008b 62.9 63.4 60.4 64.6 65.1 62.5 52.1 52.6 49.7g

2009-2015b 62.0f 62.8f 58.6 63.9 64.7 60.7 50.0 51.3 45.8


2015 60.3 60.9 57.8 61.5 62.2 58.5 50.5 50.2 51.4




Age at Diagnosis:Ages <45 77.1 73.0 87.0 81.5 77.5 90.0 59.7g 56.9g -Ages 45-54 61.3 61.5 60.3 63.6 63.3 64.6 50.6 52.9 43.3g

Ages 55-64 60.5 60.4 60.8 61.7 61.8 61.3 52.2 51.5 55.1Ages 65-74 59.3 60.4 53.7 60.0 60.9 55.5 50.3 52.6 40.1g

Ages 75+ 57.6 60.3 47.1 58.3 61.3 46.5 46.8g 46.7g 46.4h

Ages <65 61.7 61.4 63.0 63.6 63.1 65.2 52.1 52.1 51.7Ages 65+ 58.6 60.2 51.1 59.3 60.9 51.8 49.3 50.9 42.6g

Stagee:All Stages 60.3 60.9 57.8 61.5 62.1 59.2 51.1 51.7 48.7Localized 77.4 78.2 73.4 77.6 78.2 74.7 72.1 74.2 61.8Regional 44.7 43.5 48.1 45.7 44.6 48.9 39.3 37.1 44.7Distant 33.3 32.9 35.3 33.7 33.5 34.4 30.9 29.5 36.5Unstaged/Unknown 51.2 52.9 41.6g 52.7 54.4 41.8g 32.0g 30.4g -

Table 12.8Cancer of the Larynx (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 14 - - - - -1970-1973a - - - 22 - - - - -1975-1977b 34.1 33.0 35.6 34.5 33.6 35.8 33.4 30.4 36.71978-1980b 36.0 35.0 37.3 36.7 35.8 38.0 28.2 27.3 29.31981-1983b 37.3 36.9 37.8 38.1 37.8 38.5 33.9 33.4 34.31984-1986b 40.5 40.1 41.1 41.6 41.3 42.0 32.7 31.5 34.11987-1989b 42.9 44.0 41.3 43.9 45.5 41.8 35.0 32.7 37.81990-1992b 45.2 44.6 46.1 46.5 46.3 46.8 35.7 30.5 41.31993-1995b 47.6 48.4 46.4 48.7 49.5 47.5 41.3 41.6 40.91996-1998b 48.4 48.6 48.1 49.8 49.7 49.8 38.6 39.0 38.01999-2001b 51.0 52.0 49.5 52.0 53.0 50.7 43.7 45.1 42.12002-2004b 58.3 58.4 58.1 59.1 59.4 58.8 54.0 54.3 53.42005-2008b 62.3 63.5 60.7 63.3 64.3 62.0 56.0 59.9 51.12009-2015b 65.8e 67.3e 63.7e 66.8e 68.2e 64.9e 59.6e 60.9e 58.2e


2015 63.2 64.3 61.9 63.4 64.0 62.4 58.2 61.7 54.4



Table 13.14Leukemia



SEE

R C


1975-2016N


a SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).Based on follow-up of patients into 2016. Expected survival rates are derived from the U.S. Annual Life Tables.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey,Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey andGeorgia excluding ATL/RG). Expected survival rates are derived from life tables by socio-economic status, geography and racedeveloped by the SEER program.Based on follow-up of patients into 2016.

c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts. It is computed here using three year calendar blocks (2010-2012: 0-1 year survival),(2009-2011: 1-2 year survival), (2008-2010: 2-3 year survival), (2007-2009: 3-4 year survival), (2006-2008: 4-5 years survival).

d The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).e The standard error is between 5 and 10 percentage points.f The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.


Acute Lymphocytic Leukemia5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 40.6 36.9 45.6 40.8 37.4 45.7 33.5e - -...1987-1989a 54.4 53.7 55.2 55.0 54.7 55.3 44.7e 42.0e 47.1e1990-1992a 58.0 54.5 63.1 57.7 54.9 62.0 57.1e 50.4e 63.3e1993-1995a 60.2 57.8 63.6 59.8 57.8 62.7 53.2e 45.9e 63.8e1996-1998a 65.5 64.4 66.9 66.4 64.3 69.0 55.6e 59.1e 50.2e1999-2001a 63.5 63.4 63.5 64.8 65.2 64.2 56.6e 50.3e 63.0e2002-2004a 67.3 66.1 68.9 67.6 66.6 69.1 64.5e 59.4e 69.7e2005-2008a 70.1 69.3 71.3 70.0 68.6 72.0 65.2 70.0 55.1e2009-2015a 71.7d 72.3d 71.0d 72.6d 73.7d 71.3d 62.5d 60.7 64.7e

5-Year Period Survival (Percent)bc2015 69.1 68.4 69.8 68.5 67.4 70.0 65.0 65.0 64.8

5-Year Relative Survival (Percent), 2009-2015bAge at Diagnosis:Ages <45 80.6 79.5 82.1 80.7 79.1 82.8 76.3 75.7 77.0Ages 45-54 38.1 36.5 40.3 37.9 37.3 38.9 25.7e - -Ages 55-64 28.0 27.5 28.4 29.4 28.8 29.8 17.3e 22.8e -Ages 65-74 23.9 18.8 29.1 21.4 17.0 25.9 - - -Ages 75+ 9.1 9.7 8.3 10.0 9.6 10.0 0.0 - -Ages <65 73.3 72.5 74.3 73.5 72.4 74.9 66.8 66.8 66.8Ages 65+ 17.4 15.1 19.6 16.6 14.1 19.1 15.4e - 18.9e

Chronic Lymphocytic Leukemia5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 67.1 64.7 70.3 67.9 65.4 71.1 56.9e 55.1e 59.0e...1987-1989a 72.7 72.7 72.9 73.9 74.0 73.7 58.1 55.5e 61.5e1990-1992a 74.1 71.8 77.3 75.3 73.1 78.4 52.2 43.4e 60.9e1993-1995a 77.2 77.1 77.3 78.3 78.1 78.6 63.3 64.0e 62.1e1996-1998a 75.6 73.9 77.8 76.7 75.2 78.7 58.1 51.5e 66.0e1999-2001a 78.6 78.2 79.2 79.4 78.8 80.3 66.6 65.5e 66.6e2002-2004a 84.0 83.2 85.2 84.5 83.7 85.6 77.0 74.2e 80.7e2005-2008a 86.2 86.1 86.3 86.4 86.3 86.4 84.1 85.7 81.22009-2015a 88.2d 88.7d 87.5d 88.6d 88.9d 88.3d 78.5d 80.1d 76.3


5-Year Relative Survival (Percent), 2009-2015bAge at Diagnosis:Ages <45 94.0 92.7 96.0 94.2 93.2 95.4 90.5e 87.9e -Ages 45-54 93.9 93.4 94.8 94.5 93.5 96.4 84.0 88.9 76.1eAges 55-64 92.2 91.6 93.3 92.4 91.6 93.8 83.6 83.1 84.3Ages 65-74 87.4 85.6 90.5 87.6 85.3 91.3 77.3 78.4 75.6Ages 75+ 73.1 72.7 73.6 72.9 72.4 73.4 58.4 58.6e 56.4eAges <65 92.8 92.2 93.9 93.1 92.3 94.7 84.3 85.4 82.4Ages 65+ 80.1 79.6 80.7 79.9 79.2 80.7 69.1 71.3 66.2

Table 13.15Lymphocytic Leukemia



SEE

R C


1975-2016N





d The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).e The standard error is between 5 and 10 percentage points.f The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.


Acute Myeloid Leukemia5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 6.2 5.5 7.0 5.8 5.4 6.2 10.1 8.2 11.7...1987-1989a 11.5 9.2 14.1 11.3 9.7 13.2 9.2 4.4 15.7e1990-1992a 13.8 12.6 15.2 13.5 12.2 15.0 13.5 12.9 13.91993-1995a 16.1 14.9 17.4 15.3 14.1 16.7 21.5 20.6e 22.01996-1998a 17.0 15.9 18.3 15.6 14.5 17.1 22.1 25.2 18.21999-2001a 19.2 18.8 19.7 18.7 17.6 19.9 19.3 24.8 14.22002-2004a 23.4 20.9 26.4 23.2 20.8 26.0 25.3 26.5 24.02005-2008a 24.9 23.5 26.5 24.2 22.8 25.7 23.9 19.3 27.72009-2015a 29.4d 29.1d 29.8d 29.0d 28.4d 29.9d 29.2d 28.0d 30.1d


5-Year Relative Survival (Percent), 2009-2015bAge at Diagnosis:Ages <45 60.4 58.5 62.4 62.1 59.9 64.5 51.1 48.2 53.8Ages 45-54 44.1 43.9 44.4 45.6 45.0 46.3 33.7 34.2 33.6Ages 55-64 30.0 28.1 32.5 30.8 28.5 33.8 23.1 23.4 22.4Ages 65-74 13.9 13.7 14.1 14.5 14.4 14.6 10.3 7.8 13.1Ages 75+ 3.4 4.0 2.7 3.4 4.1 2.7 2.4 - 2.0Ages <65 46.6 44.4 49.1 47.4 44.9 50.4 39.3 37.1 41.4Ages 65+ 7.9 8.5 7.2 8.2 8.9 7.3 6.4 5.8 7.1

Chronic Myeloid Leukemia5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 21.8 19.3 25.1 20.5 18.4 23.4 27.7e 21.6e 35.5e...1987-1989a 30.3 30.6 29.8 30.1 31.0 29.0 33.3e 28.1e 41.3e1990-1992a 30.7 29.6 32.2 30.3 30.0 30.6 34.9e 25.5e 44.9e1993-1995a 35.5 35.3 35.8 35.2 35.1 35.2 35.6e 32.8e 40.2e1996-1998a 37.1 37.7 36.3 38.0 37.6 38.5 31.0 30.4e 31.4e1999-2001a 47.3 45.9 49.2 45.9 44.1 48.3 49.0e 49.6e 48.1e2002-2004a 54.3 53.0 56.1 52.6 51.4 54.1 63.0e 62.1e 64.0e2005-2008a 63.1 63.2 62.9 61.7 61.5 62.1 64.3 66.4e 60.8e2009-2015a 69.7d 68.1d 71.8d 69.0d 67.7d 70.7d 73.6d 71.1d 76.3d


5-Year Relative Survival (Percent), 2009-2015bAge at Diagnosis:Ages <45 89.9 88.9 91.3 91.6 90.5 93.4 79.7 78.6 81.2Ages 45-54 87.4 86.0 89.1 87.1 85.8 88.8 87.1 84.2 90.0Ages 55-64 77.6 74.8 81.6 78.1 75.0 82.6 69.8 67.6e 71.9eAges 65-74 61.1 57.9 65.6 60.9 57.8 65.4 58.4e 52.6e 63.7eAges 75+ 32.6 30.5 34.6 32.1 30.2 33.6 36.2e 36.2f 36.2eAges <65 85.1 83.6 87.3 85.6 83.9 88.3 79.0 77.3 80.8Ages 65+ 46.2 44.4 48.4 45.6 44.1 47.5 49.5 47.1e 51.5e

Table 13.16Myeloid Leukemia



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - - - - - - -1970-1973a - - - - - - - - -1975-1977b 3.4 1.8 6.3 3.4 1.9 5.8 1.8 0.0 5.61978-1980b 3.3 2.2 5.4 3.3 2.2 4.8 3.6 3.0 5.01981-1983b 3.7 2.9 5.2 4.0 3.0 5.5 2.8 2.1 4.71984-1986b 5.7 3.7 9.5 5.7 3.7 9.1 4.4 2.1 9.11987-1989b 4.9 3.2 8.0 5.7 3.4 9.4 2.7 1.6 4.91990-1992b 5.6 5.0 7.0 6.2 5.1 8.3 2.6 2.0 3.61993-1995b 5.6 5.3 6.1 5.2 4.9 5.7 4.0 2.8 7.31996-1998b 8.6 8.3 9.1 8.4 7.6 10.2 4.6 5.9 2.01999-2001b 11.3 10.9 12.1 10.3 9.6 11.7 7.6 6.8 9.52002-2004b 14.9 14.9 14.7 14.1 14.6 13.1 9.6 7.3 15.82005-2008b 17.8 17.8 17.8 16.9 17.0 16.4 12.7 11.9 15.12009-2015b 19.5f 19.6f 19.2f 18.8f 19.0f 18.1f 15.8f 16.1 14.8f


2015 18.9 18.6 19.8 18.1 17.9 18.7 16.0 15.1 18.4




Age at Diagnosis:Ages <45 39.8 36.6 45.9 46.5 43.5 51.3 25.7 24.4 28.1g

Ages 45-54 20.2 18.6 26.7 19.7 18.0 26.6 14.4 13.4 17.2Ages 55-64 20.7 19.9 24.1 20.5 19.9 23.3 15.6 13.9 21.9Ages 65-74 17.2 16.6 18.8 15.3 14.9 16.1 15.8 15.2 17.3Ages 75+ 8.7 8.8 8.5 7.4 8.0 6.6 7.2 5.8 7.8Ages <65 21.8 20.4 27.2 21.8 20.4 27.3 15.9 14.3 21.4Ages 65+ 13.5 13.6 13.2 11.8 12.3 11.0 13.1 13.1 13.0


Table 14.8Cancer of the Liver and Intrahepatic Bile Duct (Invasive)



SEE

R C


1975-2016N










2015 20.2 16.7 23.8 20.3 16.9 23.8 17.8 14.4 21.8






Table 15.12Cancer of the Lung and Bronchus (Invasive)



SEE

R C


1975-2016N


Note: Small Cell Cancer of the Lung and Bronchus includes histologies 8002, 8041-8045.a SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

Based on follow-up of patients into 2016. Expected survival rates are derived from the U.S. Annual Life Tables.b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey,



d Stage at diagnosis is classified using SEER Summary Stage 2000. Stage distribution percentages may not sum to 100 due to rounding.e The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).f The standard error is between 5 and 10 percentage points.g The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.


5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 3.6 3.1 4.8 3.7 3.1 4.9 3.7 3.8 3.61978-1980a 4.2 3.2 6.5 4.3 3.3 6.4 3.1 2.4 5.01981-1983a 4.5 3.5 6.2 4.6 3.6 6.1 5.3 4.1 8.21984-1986a 4.5 3.5 6.2 4.7 3.6 6.4 3.5 2.2 5.61987-1989a 5.1 3.9 6.6 5.1 3.9 6.8 4.0 3.3 5.11990-1992a 5.4 4.5 6.4 5.4 4.5 6.5 4.2 3.9 4.41993-1995a 6.4 5.1 7.9 6.3 5.0 7.6 6.7 4.0 10.41996-1998a 5.8 5.2 6.5 6.0 5.4 6.6 3.6 2.6 4.51999-2001a 5.8 4.8 6.8 5.6 4.4 6.9 5.2 6.0 4.22002-2004a 6.5 4.7 8.2 6.5 4.4 8.4 5.3 5.3 5.12005-2008a 6.9 5.4 8.5 6.8 5.3 8.4 7.4 5.6 9.42009-2015a 6.6e 5.1e 8.2e 6.6e 4.9e 8.2e 6.3e 5.2e 7.0

5-Year Period Survival (Percent)bc

2015 6.5 4.9 8.1 6.5 4.8 8.0 7.2 5.8 8.6

Stage Distribution (%) 2009-2015bd


5-Year Relative Survival (Percent), 2009-2015b

Age at Diagnosis:Ages <45 13.4 11.3 15.8 13.5 11.7 15.5 11.1 6.2f -Ages 45-54 9.0 6.1 11.8 8.9 5.6 11.9 11.1 9.7 12.6Ages 55-64 7.7 5.5 9.9 7.6 5.3 9.9 7.8 5.4 10.1Ages 65-74 6.0 4.9 7.1 6.0 4.7 7.2 5.8 5.9 5.6Ages 75+ 3.6 2.5 4.5 3.6 2.4 4.7 3.6 3.3 3.8Ages <65 8.2 5.8 10.6 8.1 5.5 10.6 8.9 6.8 11.0Ages 65+ 5.0 4.0 6.0 5.0 3.8 6.2 5.0 5.1 4.9

Staged:All Stages 6.3 4.7 7.9 6.3 4.5 7.9 7.0 6.0 8.0Localized 27.3 23.6 30.6 27.2 22.7 31.0 32.0f 34.2f 30.1f

Regional 15.6 13.0 17.7 15.8 13.1 18.0 15.4 12.4 17.7Distant 2.8 2.0 3.7 2.7 1.9 3.6 3.7 3.2 4.2Unstaged/Unknown 9.5 5.4 13.1 9.1 3.1 14.0 4.6 8.5f -

Table 15.13Small Cell Cancer of the Lung and Bronchus (Invasive)



SEE

R C


1975-2016N


Note: Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004, 8012-8015, 8021-8022, 8030-8035, 8046, 8050-8052,8070-8076, 8078, 8082-8084, 8090, 8094, 8120, 8123, 8140-8141, 8143-8145, 8147, 8190, 8200-8201, 8211, 8240-8241, 8243-8246,8249-8255, 8260, 8290, 8310, 8320, 8323, 8333, 8401, 8430,8440,8470-8471,8480-8481, 8490, 8503, 8507, 8525, 8550, 8560, 8562,8570-8572, 8574-8576.




d Stage at diagnosis is classified using SEER Summary Stage 2000. Stage distribution percentages may not sum to 100 due to rounding.e The difference between 1975-1977 and 2009-2015 is statistically significant (p<.05).f The standard error is between 5 and 10 percentage points.g The standard error is greater than 10 percentage points.- Statistic could not be calculated due to fewer than 25 cases during the time period.


5-Year Relative Survival (Percent)Year of Diagnosis:1975-1977a 16.4 14.8 21.1 16.8 15.0 21.5 13.4 12.4 17.71978-1980a 16.7 14.8 21.4 17.0 15.2 21.5 14.2 11.6 22.81981-1983a 17.1 15.0 21.7 17.5 15.4 22.1 13.9 12.2 19.21984-1986a 16.6 14.4 21.0 17.0 14.7 21.5 13.1 11.9 16.41987-1989a 16.9 15.2 19.8 17.3 15.5 20.5 13.2 12.9 13.91990-1992a 17.7 15.5 21.1 18.3 16.2 21.7 12.8 11.1 16.21993-1995a 18.7 16.1 22.5 19.3 16.5 23.2 15.1 13.3 18.51996-1998a 19.4 16.7 22.9 19.9 17.1 23.5 15.3 12.7 19.51999-2001a 20.0 16.9 24.1 20.7 17.6 24.6 14.8 12.0 18.92002-2004a 19.6 17.0 22.8 20.4 17.6 23.7 15.0 13.9 16.52005-2008a 21.8 18.7 25.4 22.8 19.5 26.4 16.3 13.7 19.32009-2015a 25.1e 20.8e 29.7e 25.5e 21.3e 30.1e 22.3e 18.0e 27.0e


Stage Distribution (%) 2009-2015bdAll StagesNumber of cases 198,888 105,279 93,609 158,136 82,886 75,250 24,379 13,412 10,967Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 19 17 22 20 18 23 15 13 18Regional 24 24 23 24 25 24 24 23 24Distant 55 57 52 54 56 51 60 62 56Unstaged/Unknown 2 2 2 2 2 2 2 2 2

5-Year Relative Survival (Percent), 2009-2015bAge at Diagnosis:Ages <45 36.7 31.4 41.5 39.0 32.9 44.3 28.9 25.7 32.5Ages 45-54 24.8 19.6 30.3 25.7 20.3 31.5 20.9 16.0 26.1Ages 55-64 24.3 20.0 29.9 24.8 20.5 30.2 20.1 16.2 25.8Ages 65-74 25.3 20.9 30.4 25.9 21.5 30.8 20.3 16.3 25.2Ages 75+ 19.9 16.2 23.4 20.3 16.7 23.8 15.9 11.7 19.8Ages <65 25.1 20.4 30.7 25.7 21.0 31.4 20.8 16.6 26.2Ages 65+ 22.8 18.9 27.0 23.3 19.3 27.4 18.6 14.7 22.9

Staged:All Stages 23.7 19.5 28.3 24.1 19.9 28.7 19.7 15.7 24.5Localized 61.4 54.8 66.9 61.4 55.3 66.5 57.2 47.0 66.5Regional 34.5 29.9 39.7 34.5 29.9 39.7 31.6 28.2 35.4Distant 6.1 5.0 7.5 5.9 4.7 7.3 5.7 4.6 7.1Unstaged/Unknown 14.6 13.8 15.4 13.8 12.8 14.9 11.3 10.3 12.5

Table 15.14Non-Small Cell Cancer of the Lung and Bronchus (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 60 51 68 - - -1970-1973a - - - 68 62 75 - - -1975-1977b 81.9 77.5 86.3 82.1 77.8 86.3 56.7g - -1978-1980b 82.8 77.7 87.7 82.9 77.9 87.9 59.8h - -1981-1983b 82.8 78.4 87.3 82.8 78.4 87.2 61.9g - -1984-1986b 86.6 82.6 91.0 86.4 82.3 91.0 72.3h - -1987-1989b 88.1 84.9 91.5 88.0 84.9 91.3 78.6g - 89.5g

1990-1992b 89.3 87.0 91.8 89.3 87.1 91.8 59.6g - -1993-1995b 89.7 87.3 92.6 89.6 87.1 92.6 69.5g 66.6g -1996-1998b 91.0 89.5 92.7 90.9 89.4 92.7 73.9g 68.0h 78.6g

1999-2001b 92.2 90.2 94.6 92.2 90.2 94.6 73.9g 70.9g 76.1g

2002-2004b 93.2 91.1 95.4 93.2 91.1 95.6 72.0g - 70.4g

2005-2008b 93.3 91.7 95.2 93.4 91.8 95.3 72.6g 62.7g 78.7g

2009-2015b 94.2f 92.5f 96.4f 94.1f 92.3f 96.3f 69.8g 63.0g 74.8g


2015 92.5 90.7 94.8 91.8 89.8 94.4 66.7 57.1 74.2


All StagesNumber of cases 104,803 59,231 45,572 97,299 55,300 41,999 499 223 276Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 84 82 86 83 81 86 55 50 59Regional 9 10 7 9 10 8 23 26 21Distant 4 5 3 4 5 3 16 17 16Unstaged/Unknown 4 4 4 3 3 4 5 7 4


Age at Diagnosis:Ages <45 94.7 91.5 96.9 94.5 91.1 96.8 82.5g 68.8h 89.2g

Ages 45-54 93.3 90.7 96.0 92.9 90.1 95.9 66.3g 60.5g 72.2g

Ages 55-64 92.4 90.6 95.2 91.9 90.1 94.8 65.7g 52.9g 78.9g

Ages 65-74 93.0 91.8 95.0 92.4 91.2 94.7 70.3g 62.3h 73.3g

Ages 75+ 87.0 86.6 87.6 85.6 85.0 86.6 41.8g 34.9h 43.3h

Ages <65 93.3 90.8 96.1 93.0 90.4 95.9 71.7 59.9g 81.4Ages 65+ 90.4 89.7 91.5 89.4 88.6 90.8 57.5g 52.4h 59.3g

Stagee:All Stages 92.2 90.4 94.6 91.6 89.6 94.2 66.8 58.5 73.0Localized 98.7 98.2 99.4 98.3 97.6 99.1 87.8 87.3g 87.5Regional 64.7 62.1 69.3 65.0 62.4 69.6 49.2g 41.5g 56.7g

Distant 24.8 23.4 27.7 24.7 23.7 26.9 27.5g - 40.1g

Unstaged/Unknown 85.4 83.0 88.4 83.8 81.1 87.0 41.4h - -

Table 16.8Melanoma of the Skin (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - - - - - - -1970-1973a - - - - - - - - -1975-1977b 9.7 3.0 26.7 10.4 3.3 27.4f - - -1978-1980b 6.0 5.5 8.1 5.9 5.2 8.7 - - -1981-1983b 7.7 5.3 15.1 8.1 5.4 16.2 - - -1984-1986b 6.6 4.3 13.9 6.1 3.7 14.1 - - -1987-1989b 6.2 4.6 12.2 6.3 4.8 12.1 4.8 - -1990-1992b 7.7 4.2 20.6 7.4 4.1 20.1 10.2f 8.5f -1993-1995b 6.5 3.2 18.7 5.9 2.8 18.0 9.0 8.0f -1996-1998b 9.8 8.2 15.2 9.8 8.0 16.2 11.4f - -1999-2001b 7.6 5.3 15.9 6.7 5.0 13.0 - - -2002-2004b 6.6 4.9 11.6 6.1 4.5 10.9 7.9f - -2005-2008b 9.4 7.0 17.0 10.1 7.2 19.7 4.3 - -2009-2015b 10.6 7.6e 19.7 10.0 7.3e 18.5 16.8f 0.0 -


2015 10.1 7.8 16.6 9.4 7.4 15.6 18.6 13.2 26.5


Age at Diagnosis:Ages <45 46.6 35.2f 58.8f 44.5f 35.0f 56.7f - - -Ages 45-54 21.1 14.1 32.4f 19.5 13.6 30.5f 26.0f - -Ages 55-64 15.2 14.2 17.8 14.5 13.6 16.9 19.2f 15.4f -Ages 65-74 9.4 7.8 15.6 9.5 8.0 15.4 10.1 8.6f -Ages 75+ 4.3 3.5 6.7 4.1 3.1 7.0 5.1 3.3 -Ages <65 20.2 16.2 28.2 18.9 15.6 25.7 28.3f 16.5f 41.9f

Ages 65+ 6.5 5.3 10.2 6.4 5.2 10.3 7.6 6.0 10.4f

Table 17.4Mesothelioma



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 12 13 10 - - -1970-1973a - - - 19 20 17 - - -1975-1977b 24.6 23.9 25.3 24.1 23.6 24.7 29.3 28.9 29.51978-1980b 25.9 24.4 27.5 24.8 24.1 25.5 32.5 27.4 37.51981-1983b 27.5 25.7 29.4 27.2 25.4 28.9 28.9 29.6 27.91984-1986b 27.3 27.7 26.8 26.0 25.8 26.2 31.8 33.3 30.31987-1989b 27.2 28.8 25.6 26.8 29.1 24.5 30.0 29.3 30.61990-1992b 29.3 30.6 27.9 28.4 29.7 26.9 34.2 38.0 30.61993-1995b 31.7 32.3 31.0 30.5 31.4 29.5 35.4 34.9 35.71996-1998b 32.5 34.5 30.4 32.3 34.4 29.9 31.6 32.9 30.61999-2001b 34.6 37.0 31.9 34.5 37.0 31.5 34.4 37.2 32.02002-2004b 42.6 43.6 41.4 43.4 44.8 41.6 40.7 40.8 40.72005-2008b 47.5 47.8 47.1 47.1 48.3 45.4 49.5 45.8 52.72009-2015b 53.7f 54.4f 52.9f 53.2f 54.1f 52.0f 55.1f 54.8f 55.4f


2015 53.0 52.5 53.6 51.8 51.3 52.4 55.0 54.6 55.4





Stagee:All Stages 52.2 52.1 52.4 51.3 51.3 51.3 53.9 53.4 54.4Localized 73.9 73.7 73.9 73.9 74.0 73.6 71.4 71.0g 71.5g

Regional - - - - - - - - -Distant 51.1 50.8 51.4 50.1 50.0 50.2 53.2 52.6 53.8Unstaged/Unknown - - - - - - - - -

Table 18.8Myeloma



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 31 31 31 - - -1970-1973a - - - 41 39 43 - - -1975-1977b 46.5 45.6 47.5 46.8 46.3 47.3 48.6 42.6 55.3g

1978-1980b 47.9 46.1 49.8 47.9 46.2 49.5 51.1 46.9 56.71981-1983b 50.6 50.3 50.9 50.8 50.5 51.1 49.5 49.2 49.81984-1986b 51.6 50.1 53.4 52.1 50.7 53.7 46.8 44.5 49.91987-1989b 50.9 47.6 54.9 51.3 48.2 55.2 45.7 41.3 51.01990-1992b 50.7 46.7 55.7 51.5 47.6 56.4 42.2 38.4 47.61993-1995b 52.6 48.7 57.5 53.3 49.8 57.7 42.5 35.9 54.91996-1998b 58.8 57.0 61.0 59.5 57.7 61.5 54.7 53.1 57.21999-2001b 64.0 61.4 67.0 65.0 62.8 67.6 55.8 49.0 63.82002-2004b 69.8 68.6 71.2 71.0 70.1 72.1 63.6 61.1 66.62005-2008b 71.6 70.6 72.7 72.8 71.9 73.8 62.5 57.8 67.52009-2015b 74.7f 73.9f 75.7f 75.7f 74.8f 76.7f 69.5f 67.0f 72.4f


2015 72.2 70.5 74.3 72.6 70.8 74.7 67.1 64.1 70.3






Table 19.8Non-Hodgkin Lymphoma



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 45 - - - - -1970-1973a - - - 43 - - - - -1975-1977b 52.5 51.6 54.8 54.1 53.8 54.7 36.0 29.7 49.01978-1980b 53.3 51.8 56.5 55.4 54.5 57.4 34.9 29.8 45.81981-1983b 51.7 50.1 55.1 54.0 52.8 56.5 30.9 25.4 45.61984-1986b 54.1 51.7 59.0 56.3 54.8 59.4 35.0 29.5 49.11987-1989b 53.6 51.0 58.8 56.0 54.1 59.8 34.0 30.0 44.01990-1992b 55.4 53.2 60.1 57.9 56.4 61.0 33.1 28.4 46.01993-1995b 57.7 56.2 60.6 60.1 59.4 61.3 38.0 33.1 50.51996-1998b 57.8 56.2 61.0 59.9 59.1 61.4 36.4 31.3 49.51999-2001b 60.3 59.2 62.5 62.2 62.0 62.7 44.6 39.6 57.12002-2004b 63.9 63.1 65.7 65.7 65.7 65.7 48.2 42.8 58.82005-2008b 65.5 65.1 66.5 67.4 67.2 67.9 43.0 40.7 48.02009-2015b 68.4f 67.6f 70.4f 70.3f 69.9f 71.4f 50.9f 49.2f 54.4


2015 65.8 65.2 67.4 67.2 66.8 68.2 49.3 48.3 51.5






Table 20.10Cancer of the Oral Cavity and Pharynx (Invasive)



SEE

R C


1975-2016N


Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.a Based on End Results data from a series of hospital registries and one population-based registry.b SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).






5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 32 - - 32 - -1970-1973a - - - 36 - - 32 - -1975-1977b 35.9 44.1 21.4 35.3 43.5 21.1 41.6 48.6 24.9g1978-1980b 37.7 47.3 22.1 36.9 46.5 22.3 38.8 49.2 12.81981-1983b 38.9 50.3 23.1 38.5 50.2 23.1 37.9 46.0 22.61984-1986b 38.4 49.4 24.1 37.5 48.5 23.8 39.2 51.9 21.21987-1989b 38.2 51.1 23.6 38.2 51.3 23.9 33.9 47.2 17.11990-1992b 40.6 55.5 24.1 40.4 56.1 24.1 35.7 49.4 16.81993-1995b 41.6 55.9 26.5 40.7 55.5 26.0 41.3 54.8 26.41996-1998b 43.9 57.1 28.4 43.3 56.6 28.5 39.2 53.3 20.41999-2001b 43.9 56.0 29.0 43.7 56.6 28.9 35.5 43.9 21.92002-2004b 43.8 57.0 27.0 43.3 56.8 27.2 36.7 46.5 20.82005-2008b 45.3 58.8 27.3 44.9 58.8 27.7 38.2 46.6 24.02009-2015b 48.4f 60.7f 31.5f 48.1f 61.1f 31.9f 40.3 50.1 22.6

5-Year Period Survival (Percent)cd2015 47.8 59.5 31.8 47.7 60.3 32.2 38.6 48.4 20.6

Stage Distribution (%) 2009-2015ceAll StagesNumber of cases 34,359 19,644 14,715 27,885 15,319 12,566 3,060 1,881 1,179Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 15 20 7 14 20 7 15 19 7Regional 21 25 15 20 25 15 16 19 12Distant 59 51 69 60 52 69 62 57 71Unstaged/Unknown 6 3 9 6 3 8 7 5 9

5-Year Relative Survival (Percent), 2009-2015cAge at Diagnosis:Ages <45 76.0 - - 76.9 - - 70.3 - -Ages 45-54 59.7 - - 60.7 - - 47.3 - -Ages 55-64 51.1 - - 52.2 - - 38.7 - -Ages 65-74 39.7 - - 40.6 - - 26.2 - -Ages 75+ 22.0 - - 22.5 - - 13.4 - -Ages <65 59.7 - - 60.3 - - 49.7 - -Ages 65+ 30.9 - - 31.5 - - 20.5 - -

Stagee:All Stages 47.6 59.7 30.9 47.6 60.3 31.5 38.8 49.7 20.5Localized 92.4 93.9 86.5 93.2 94.8 87.4 86.2 89.1 72.2gRegional 75.2 81.7 60.4 75.7 82.7 61.0 64.9 72.0 46.3gDistant 29.2 36.7 21.5 29.6 37.6 22.0 22.0 28.5 12.9Unstaged/Unknown 24.3 53.3 9.1 22.3 51.5 9.2 29.0 58.8g 5.4

Table 21.8Cancer of the Ovary(Invasive)



SEE

R C


1975-2016N










2015 10.1 10.2 10.0 10.0 10.2 9.7 10.2 9.3 11.0






Table 22.8Cancer of the Pancreas (Invasive)



SEE

R C


1975-2016N







All Races, Males White Males Black Males All <65 65+ All <65 65+ All <65 65+

5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 50 - - 35 - -1970-1973a - - - 63 - - 55 - -1975-1977b 67.8 73.4 66.1 68.5 75.2 66.6 60.7 62.0 60.11978-1980b 70.1 75.2 68.6 71.2 76.7 69.6 62.1 65.0 60.61981-1983b 72.0 76.0 70.9 73.1 77.6 71.9 62.8 65.0 61.91984-1986b 75.2 77.4 74.6 76.4 79.1 75.7 65.6 67.2 64.91987-1989b 82.8 83.2 82.7 84.4 84.7 84.3 71.1 72.8 70.61990-1992b 92.9 93.0 92.9 94.1 94.0 94.1 84.5 86.8 83.61993-1995b 95.2 95.9 94.9 96.0 96.6 95.7 91.8 93.4 90.91996-1998b 97.4 98.5 96.7 97.9 99.0 97.4 95.0 96.7 93.71999-2001b 99.3 99.1 99.3 99.7 99.5 99.6 97.4 98.0 96.42002-2004b 99.7 99.5 99.7 99.8 99.6 99.7 97.9 99.2 96.32005-2008b 99.5 99.5 99.5 99.8 99.9 99.6 98.2 98.4 97.92009-2015b 98.6f 99.2f 98.1f 99.0f 99.6f 98.6f 96.5f 97.9f 94.5f


2015 97.5 98.1 97.0 97.5 98.2 96.9 95.1 96.9 92.7






Table 23.8Cancer of the Prostate (Invasive)



SEE

R C


1975-2016N










2015 31.8 28.7 36.5 30.5 27.3 35.9 33.0 27.9 39.3






Table 24.8Cancer of the Stomach (Invasive)



SEE

R C


1975-2016N







All Races, Males White Males Black Males All <50 50+ All <50 50+ All <50 50+

5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 63 - - - - -1970-1973a - - - 72 - - - - -1975-1977b 82.6 83.3 77.6 82.6 83.3 77.3 - - -1978-1980b 88.8 89.5 82.2 89.2 89.8 83.1 73.1g 78.0g -1981-1983b 92.0 92.5 85.5 92.2 92.8 86.2 87.7g 84.7g -1984-1986b 92.6 93.6 80.4 92.9 94.0 80.6 87.0g 89.4g -1987-1989b 95.2 95.0 95.7 95.5 95.4 95.3 88.0g 87.4g -1990-1992b 95.8 95.8 93.7 96.2 96.1 94.6 84.2g 89.0g -1993-1995b 95.8 96.4 86.7 96.1 96.6 87.8 88.0 89.4 -1996-1998b 95.6 96.3 86.6 95.8 96.5 86.6 89.0 90.3 -1999-2001b 96.2 96.4 91.9 96.5 96.7 92.8 87.6 89.0 -2002-2004b 96.0 96.5 89.8 96.5 97.0 90.9 85.1 84.8g -2005-2008b 96.9 97.0 95.4 97.4 97.5 96.1 89.8 88.7 -2009-2015b 96.8f 97.0f 94.8f 97.0f 97.3f 95.1f 92.7 92.7 91.9g


2015 94.8 95.5 90.0 94.9 95.7 89.9 91.7 91.9 88.9


All StagesNumber of cases 16,433 14,472 1,961 14,594 12,829 1,765 520 440 80Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 68 68 65 68 68 65 62 60 70Regional 19 19 19 19 19 19 21 22 14Distant 12 12 13 12 12 13 15 15 11Unstaged/Unknown 1 1 3 1 1 2 3 2 5


Age at Diagnosis:Ages <45 95.6 - - 95.7 - - 92.0 - -Ages 45-54 95.4 - - 95.6 - - 89.2 - -Ages 55-64 91.0 - - 90.6 - - 97.0 - -Ages 65-74 86.2 - - 86.0 - - - - -Ages 75+ 80.8g - - 83.2g - - - - -Ages <65 95.4 - - 95.5 - - 92.3 - -Ages 65+ 85.0 - - 85.6 - - - - -

Stagee:All Stages 95.2 95.7 91.5 95.3 95.8 91.6 91.8 92.4 88.2Localized 99.2 99.2 99.0 99.2 99.2 99.0 98.6 98.4 97.1Regional 96.4 96.8 93.1 96.6 96.9 93.7 89.3 89.9 -Distant 72.8 75.1 57.1 73.6 75.9 58.3 68.2g 71.2g -Unstaged/Unknown 79.5 88.0 49.2g 77.8 86.6 49.6g - - -

Table 25.8Cancer of the Testis (Invasive)



SEE

R C


1975-2016N








5-Year Relative Survival (Percent)Year of Diagnosis:1960-1963a - - - 83 75 87 - - -1970-1973a - - - 86 82 87 - - -1975-1977b 92.1 91.1 92.5 91.8 90.7 92.2 89.8 - 91.01978-1980b 92.1 87.2 93.6 91.5 87.5 92.7 90.2 68.0h 95.51981-1983b 93.6 92.2 93.9 93.1 90.9 93.7 96.4 100.0 93.21984-1986b 93.2 89.9 94.3 93.2 89.4 94.4 89.5 86.1g 90.31987-1989b 94.4 91.6 95.2 94.1 91.6 95.0 92.3 91.2g 92.31990-1992b 94.3 90.5 95.6 94.9 91.6 96.0 85.9 84.5g 86.31993-1995b 95.4 91.6 96.7 95.6 91.5 96.9 93.2 87.4g 94.31996-1998b 95.6 91.0 96.9 95.9 91.3 97.3 95.1 86.5g 96.51999-2001b 96.5 94.3 97.1 96.8 94.9 97.4 92.1 88.4g 92.42002-2004b 97.3 93.9 98.2 97.4 94.1 98.3 95.9 94.0 96.02005-2008b 98.0 96.0 98.5 98.2 96.2 98.7 96.6 91.5 97.32009-2015b 98.5f 96.3f 99.0f 98.8f 96.9f 99.2f 96.9 92.3 97.6f


2015 98.1 95.6 98.9 98.4 96.0 99.0 96.6 92.4 97.4


All StagesNumber of cases 76,946 17,814 59,132 61,428 14,699 46,729 5,437 956 4,481Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%Localized 67 58 70 67 58 70 80 72 81Regional 27 34 26 28 34 26 14 18 13Distant 4 6 3 4 6 3 5 8 4Unstaged/Unknown 2 2 2 2 2 2 2 2 2


Age at Diagnosis:Ages <45 99.7 99.1 99.8 99.7 99.3 99.8 99.2 96.8 99.6Ages 45-54 99.0 96.7 99.5 98.9 96.8 99.5 99.1 97.2 99.4Ages 55-64 98.0 95.1 99.0 98.2 95.0 99.3 95.5 93.2 95.8Ages 65-74 96.7 92.6 97.6 97.0 93.4 97.8 94.2 81.8g 96.9Ages 75+ 87.0 83.9 87.9 89.4 86.9 89.6 76.0 71.4g 74.9Ages <65 99.1 97.2 99.6 99.1 97.2 99.6 98.5 96.2 98.8Ages 65+ 93.9 90.1 94.7 94.7 91.5 95.3 89.1 80.4g 90.8

Stagee:All Stages 98.2 95.7 98.9 98.4 96.1 99.0 97.2 93.3 97.8Localized 99.9 99.8 100.0 99.9 99.9 100.0 99.9 99.3 100.0Regional 98.2 96.1 99.0 98.3 96.4 99.1 93.9 86.3 96.0Distant 56.2 52.0 59.0 56.8 52.1 60.1 48.7 46.3g 49.7Unstaged/Unknown 89.1 82.5 91.3 89.0 85.1 90.4 84.3 - 86.4

Table 26.8Cancer of the Thyroid (Invasive)



SEE

R C


1975-2016N









1978-1980b 73.9 75.1 70.4 74.7 75.4 72.3 54.5 62.6 40.11981-1983b 76.7 78.1 72.8 77.4 78.6 74.0 59.5 64.9 47.0g

1984-1986b 76.7 78.1 72.7 77.2 78.4 73.6 59.4 62.3 52.81987-1989b 79.0 81.3 71.9 79.8 82.0 73.1 62.6 67.5 52.91990-1992b 79.2 81.7 71.9 80.2 82.6 73.1 63.3 66.0 58.51993-1995b 80.2 82.1 75.0 81.1 82.5 76.9 60.8 68.1 46.21996-1998b 79.1 80.4 75.4 79.8 81.1 76.0 62.9 65.9 56.01999-2001b 80.0 80.9 77.2 81.0 81.5 79.4 67.7 72.1 60.12002-2004b 79.9 81.7 74.7 80.8 82.3 76.3 61.4 66.7 52.12005-2008b 79.4 80.9 74.6 80.2 81.5 75.9 65.0 69.6 55.92009-2015b 78.3f 79.1f 75.6f 79.1f 79.7f 77.0f 64.9f 68.7f 57.6f


2015 77.0 78.2 73.3 77.5 78.4 74.4 63.5 67.1 56.9


All StagesNumber of cases 90,571 68,619 21,952 79,585 60,831 18,754 5,209 3,448 1,761Percent 100% 100% 100% 100% 100% 100% 100% 100% 100%In Situ 51 52 50 52 52 51 40 44 34Localized 34 34 33 34 35 32 37 36 38Regional 7 7 8 7 7 8 10 9 13Distant 5 4 6 4 4 6 9 7 11Unstaged/Unknown 3 3 3 3 2 3 4 4 4


Age at Diagnosis:Ages <45 87.4 88.7 84.0 88.2 89.1 85.9 72.2 76.2 61.7g

Ages 45-54 83.6 84.0 82.2 84.6 84.8 83.9 69.2 72.1 62.1Ages 55-64 81.5 81.7 80.8 82.1 82.0 82.4 68.5 70.9 61.7Ages 65-74 80.3 81.0 77.9 80.6 81.3 78.2 67.1 69.6 61.6Ages 75+ 69.4 71.4 64.0 69.9 71.6 65.3 54.2 60.5 46.5Ages <65 82.5 82.8 81.4 83.1 83.2 83.1 69.1 71.7 62.0Ages 65+ 74.4 76.0 69.6 74.8 76.2 70.5 60.6 65.5 52.7

Stagee:All Stages 77.1 78.3 73.2 77.5 78.5 74.3 64.3 68.5 56.0In Situ 95.8 95.4 97.2 95.8 95.3 97.3 92.2 92.1 92.3Localized 69.5 71.8 62.0 69.7 71.8 62.5 60.6 66.0 50.6Regional 36.3 37.2 34.0 37.2 38.3 34.0 28.8 25.0 33.0Distant 4.6 5.0 3.9 4.6 4.7 4.3 2.6 3.8 1.1Unstaged/Unknown 47.3 51.9 35.9 45.4 49.4 34.9 40.2 49.1g 21.2g

Table 27.8Cancer of the Urinary Bladder (Invasive and In Situ)



Figure 29.3

Childhood Cancer5-Year Observed Survival (%)

by ICCC Group and Race/EthnicityBoth Sexes, Under 20 Years of Age, 2009-2015

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).International Classification of Childhood Cancer is based on ICD-O-3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer. April 1, 2005: Vol 103, No. 7,pg 1457-1467.Excludes myelodysplastic sydromes (MDS) and benign brain tumors.American Indian/Alaska Native. Survival data for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/AlaskaNatives. Survival data for Hispanics are based on NHIA and excludes cases from the Alaska Native Registry.

0

20

40

60

80

100

LymphoidLeukemias

Other Leukemia Lymphoma Brain/CNS Other

White Black AI/AN

Asian/Pacific Islander Hispanic

5-Year Observed Survival

ICCC Site

c

b

a

a

b

c


Documents

SEER Cancer Statistics Review 1975-2016 National Cancer Institute · 2019-04-11 · Expected survival rates are derived from life tables by socio-economic status, geography and race